MET and leukemia: The compounds synthesized with the above-mentioned strategy were tested for MET kinase inhibitory activity in the enzyme-based and cell-based assays and also their antiproliferative effects against several solid tumors and leukemia cell lines, including MET-dependent cancer cells in two- and three-dimensional cell culture models.